Description
SATURDAY, AUGUST 29, 2026
Understanding Motivating Factors Behind Psychoactive Substance Use and Misuse: Why This Should Matter to Healthcare Providers
8:00-9:30am: 1.5 CEUs C/G/T
Alicia Lopez, PharmD, Psychiatric Pharmacist & Harm Reduction Consultant, Independent Contractor
Upon completion of this activity, pharmacists will be able to: Define terms relevant to this discussion on substance use; Describe psychosocial motivators for substance use; Describe biological motivators for substance use; Identify factors that may influence what substance(s) someone uses; Explain why understanding the factors influencing substance use is important for healthcare providers.
UAN: 0675-0000-26-025-L08-P
Upon completion of this activity, technicians will be able to: Define terms relevant to this discussion on substance use; Describe psychosocial motivators for substance use; Describe biological motivators for substance use; Identify factors that may influence what substance(s) someone uses; Explain why understanding the factors influencing substance use is important for healthcare providers.
UAN: 0675-0000-26-025-L08-T
Shaken, Not Stirred: A Review of Severe Alcohol Withdrawal Syndrome
9:30-11:00am: 1.5 CEUs C/G/T
Bethany Stavely, PharmD, Clinical Pharmacist, UF Health Jacksonville
Upon completion of this activity, pharmacists will be able to: Define alcohol withdrawal syndrome; Examine the underlying pathophysiology of alcohol withdrawal; Evaluate evidence-based pharmacologic treatment strategies in the emergency and intensive care settings.
UAN: 0675-0000-26-026-L08-P*
Upon completion of this activity, technicians will be able to: Define alcohol withdrawal syndrome; Examine the underlying pathophysiology of alcohol withdrawal; Evaluate evidence-based treatment strategies in the emergency and intensive care settings. UAN: 0675-0000-26-026-L08-T*
Legal Highs or Hidden Hazards? A Tour of the Gas Station Pharmacy!
11:15-12:45pm: 1.5 CEUs C/G/T
Joseph Cammilleri, PharmD, BCACP, CPE, Ambulatory Care Clinical Pharmacist, Pain Management, PGY2 Pain and Palliative Care Program Director, UF Clinical Assistant Professor, UF Health Jacksonville
Upon completion of this activity, pharmacists will be able to: Identify the most popular “legal high” substances sold at gas stations and smoke shops; Explain why these products are perceived as safe; Describe the specific health risks and addiction potential of these products; Discuss the current and changing legal landscape in Florida.
UAN: 0675-0000-26-027-L08-P
Upon completion of this activity, technicians will be able to: Identify the most popular “legal high” substances sold at gas stations and smoke shops; Explain why these products are perceived as safe; Describe the specific health risks and addiction potential of these products; Discuss the current and changing legal landscape in Florida.
UAN: 0675-0000-26-027-L08-T
The Intersection of Tobacco Products, Cannabis and Mental Health
12:45-2:15pm 1.5 CEUs C/G/T
Angela Hill, PharmD, CRPh, FAACP, Professor, Department of Pharmacotherapeutics & Clinical Research, Program Director, WE-CARE, University of South Florida Taneja College of Pharmacy
Upon completion of this activity, pharmacists will be able to: Compare the mechanistic ways tobacco from cigarettes, vaping, hookah, and cannabis affect brain function; Explain how tobacco use can increase the risk for depression , anxiety and other brain health issues; Differentiate ways to minimize the risks of tobacco and cannabis use on brain health; Choose key strategies to mitigate the use of tobacco products and other substances.
UAN: 0675-0000-26-028-L08-P*
Upon completion of this activity, technicians will be able to: Compare the mechanistic ways tobacco from cigarettes, vaping, hookah, and cannabis affect brain function; Explain how tobacco use can increase the risk for depression , anxiety and other brain health issues; Differentiate ways to minimize the risks of tobacco and cannabis use on brain health; Choose key strategies to mitigate the use of tobacco products and other substances.
UAN: 0675-0000-26-028-L08-T*
SUNDAY, AUGUST 30, 2026
Not Just Street Drugs: The Growing Crisis of Prescription Opioid, Sedative & Stimulant Misuse
8:00-9:30am: 1.5 CEUs C/G/T
Paige Broccio, PharmD, BCPS, Clinical Specialist, Ambulatory Care, UF Health Jacksonville
Upon completion of this activity, pharmacists will be able to: Recognize some of the most misused prescription medications and their common misuse patterns; Describe health risks and consequences associated with misusing these medications; Identify some common signs of misuse or diversion of these medications; Discuss safe prescribing practices and prevention strategies that can reduce misuse of these medications.
UAN: 0675-0000-26-029-L08-P
Upon completion of this activity, technicians will be able to: Recognize some of the most misused prescription medications and their common misuse patterns; Describe health risks and consequences associated with misusing these medications; Identify some common signs of misuse or diversion of these medications; Discuss safe prescribing practices and prevention strategies that can reduce misuse of these medications.
UAN: 0675-0000-26-029-L08-T
Bump in the Road: Management of Psychiatric Medications in Pregnancy 9:30-11:00am: 1.5 CEUs C/G/T
Alana Jula, PharmD, Clinical Pharmacist, Medical University of South Carolina Health
Upon completion of this activity, pharmacists will be able to: Identify the safety considerations of the use of psychiatric medications during pregnancy; Analyze current guideline recommendations for managing psychiatric disorders in pregnant patients; Examine the potential fetal impacts of in-utero exposure to psychiatric medications; Recommend evidence-based medication strategies to optimize maternal and fetal outcomes.
UAN: 0675-0000-26-30-L01-P*
Upon completion of this activity, technicians will be able to: Identify the safety considerations of the use of psychiatric medications during pregnancy; Recognize current guideline recommendations for managing psychiatric disorders in pregnant patients; Examine the potential fetal impacts of in-utero exposure to psychiatric medications.
UAN: 0675-0000-26-30-L01-T*
Cannabis in Healthcare: Understanding the Medical and Legal Landscape
11:15-12:45pm: 1.5 CEUs C/G/T
Sarah Steinhardt Reiger, PharmD, JD, MS, Adjunct Professor, Pharmacy Law, Manchester University College of Health Professions, Nursing and Pharmacy
Upon completion of this activity, pharmacists will be able to: Describe the pharmacology and physiological effects of medical cannabis; Discuss the evolution of medical marijuana law in the United States; Review clinical indications and use of medical cannabis in different patient populations; Identify the legal issues for clinicians associated with medical cannabis use for patients; Explore strategies for communicating with patients about medical cannabis use.
UAN: 0675-0000-26-031-L08-P
Upon completion of this activity, technicians will be able to: Describe the effects of medical cannabis; Discuss the evolution of medical marijuana law in the United States; Review clinical indications and use of medical cannabis in different patient populations; Identify the legal issues for clinicians associated with medical cannabis use for patients.
UAN: 0675-0000-26-031-L08-T
Strategies for Assessing Substance Abuse Disorders
12:45pm-2:15pm: 1.5 CEUs C/G/T
Angela Hill, PharmD, CRPh, FAACP, Professor, Department of Pharmacotherapeutics & Clinical Research, Program Director, WE-CARE, University of South Florida Taneja College of Pharmacy
Upon completion of this activity, pharmacists will be able to: Use tools designed to screen for illicit substance use and misuse; Use tools designed to screen, assess and distinguish and differentiate substance use and mental health; Describe techniques that can be used during patient encounters to reinforce medication adherence; Identify and utilize resources to assist individuals with substance use disorders.
UAN: 0675-0000-26-032-L08-P*
Upon completion of this activity, technicians will be able to: Use tools designed to screen for illicit substance use and misuse; Use tools designed to screen, assess and distinguish and differentiate substance use and mental health; Utilize resources to assist individuals with substance use disorders.
UAN: 0675-0000-26-032-L08-T*
